It's time to check in with the governing party to see how its plan to replace Obamacare is progressing.
Our Editorial Code of Ethics, which is regularly updated and also can be found under the "About Us" section of ModernHealthcare.com, offers the parameters under which we work.
Who's responsible for making the U.S. healthcare system the most expensive in the world? If you are a top hospital or insurance executive, a well-paid physician or a drug company official or stockholder, the answer lies in the mirror.
Dr. Scott Gottlieb is by far the most conflicted person nominated to run the 111-year-old Food and Drug Administration. If the Office of Government Ethics was doing its job, it wouldn't let him near the commissioner's chair for at least a year.
It was notable that so many conservative activists and pundits rushed to abandon the Republican Party's promise to “repeal and replace” Obamacare in the wake of Trumpcare's humiliating defeat in the House of Representatives.
The House of Representatives last week postponed voting to gut Obamacare after new provisions weakening the essential benefits guarantee failed to win support from right-wing Republicans, who are opposed to any form of subsidized health insurance.
Taking Merrill Goozner's place as editor of Modern Healthcare will be Aurora Aguilar.
It's time to start calling the American Health Care Act by its true name—the Force Older and Poorer Americans to Postpone Health Care Act.
Last week, the nation's hospital and physician groups joined patient, consumer and senior advocates in condemning the newly introduced American Health Care Act, which guts Medicaid and provides inadequate subsidies for buying individual health insurance plans.
What might HHS Secretary Tom Price say in response to President Trump's claim that healthcare reform is "complicated"?
Bryce Olson, a 47-year-old Intel marketing executive wants to link medical records from across the U.S. and the world into a vast virtual warehouse for research.
The Trump administration has thrown its weight behind giving patients the “right to try” experimental drugs outside clinical trials. While such laws purport to offer hope for the dying, they will actually slow medical progress.